Five years before diagnosis, brain cancer causes changes detectable in blood

June 1, 2017 by Misti Crane, The Ohio State University
Electron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer Institute

Changes in immune activity appear to signal a growing brain tumor five years before symptoms arise, new research has found.

Interactions among proteins that relay information from one immune cell to another are weakened in the blood of patients within five years before the cancer is diagnosed, said lead researcher Judith Schwartzbaum of The Ohio State University.

That information could one day lead to earlier diagnosis of brain cancer, said Schwartzbaum, an associate professor of epidemiology and member of Ohio State's Comprehensive Cancer Center.

The study, published in the journal PLOS ONE, focused on gliomas, which make up about 80 percent of brain cancer diagnoses. Average survival time for the most common type of glioma is 14 months.

Symptoms vary and include headaches, memory loss, personality changes, blurred vision and difficulty speaking. On average, the cancer is diagnosed three months after the onset of symptoms and when tumors are typically advanced.

"It's important to identify the early stages of development if we hope to intervene more effectively," Schwartzbaum said. "If you understand those early steps, maybe you can design treatments to block further ."

While widespread blood testing of people without symptoms of this rare tumor would be impractical, this research could pave the way for techniques to identify brain cancer earlier and allow for more-effective treatment, Schwartzbaum said.

Schwartzbaum evaluated blood samples from 974 people, half of whom went on to receive a brain-cancer diagnosis in the years after their blood was drawn. The samples came from Norway's Janus Serum Bank.

Because of previous research - including her own on the relationship between allergies and brain cancer - Schwartzbaum was interested in the role of cytokines, proteins that communicate with one another and with immune cells to spark immune responses. Schwartzbaum's previous work found that allergies appeared to offer protection against brain cancer.

In this study, Schwartzbaum evaluated 277 cytokines in the blood samples and found less cytokine interaction in the blood of people who developed cancer.

"There was a clear weakening of those interactions in the group who developed brain cancer and it's possible this plays a role in tumor growth and development," Schwartzbaum said.

Cytokine activity in cancer is especially important to understand because it can play a good-guy role in terms of fighting tumor development, but it also can play a villain and support a tumor by suppressing the immune system, she said.

In addition to discovering the weakening of cytokine interactions in the of future cancer patients, the researchers found a handful of cytokines that appear to play an especially important role in glioma development.

The results of this study must be confirmed and further evaluated before it could translate to changes in the earlier diagnosis of , but the discovery offers important insights, Schwartzbaum said.

"It's possible this could also happen with other tumors - that this is a general sign of ," she said.

Explore further: Surprising link between blood sugar and brain cancer found

Related Stories

Surprising link between blood sugar and brain cancer found

May 3, 2017
New research further illuminates the surprising relationship between blood sugar and brain tumors and could begin to shed light on how certain cancers develop.

A hint of increased brain tumor risk—five years before diagnosis

September 9, 2015
A new study suggests that changes in immune function can occur as long as five years before the diagnosis of a brain tumor that typically produces symptoms only three months before it is detected.

High blood sugar could mean lower risk of one type of brain tumor

June 20, 2016
In a surprising twist, benign brain tumors that have previously been tied to obesity and diabetes are less likely to emerge in those with high blood sugar, new research has found.

People with allergies may have lower risk of brain tumors

August 3, 2012
(Medical Xpress) -- New research adds to the growing body of evidence suggesting that there's a link between allergies and reduced risk of a serious type of cancer that starts in the brain. This study suggests the reduced ...

Immune cells play crucial role in brain cancer development

May 2, 2017
Brain tumors recruit immune cells derived from bone marrow to transform what began as benign masses into deadly malignancies, according to two studies from Weill Cornell Medicine scientists. The findings suggest that inhibiting ...

Recommended for you

Treatment shown to improve the odds against bone marrow cancer

December 15, 2018
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.